Discovery of 4-amino-2-(thio)phenol derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part II

被引：12

作者：

Xu, Fuming ^{[1
]}

Zhang, Lei ^{[1
]}

Jia, Yuping ^{[2
]}

Wang, Xuejian ^{[1
]}

Li, Xiaoguang ^{[1
]}

Wen, Qingli ^{[3
]}

Zhang, Yingjie ^{[1
]}

Xu, Wenfang ^{[1
]}

机构：

[1] Shandong Univ, Sch Pharm, Dept Med Chem, Jinan 250012, Shandong, Peoples R China

[2] Shandong Inst Pharmaceut Ind, Jinan 250101, Shandong, Peoples R China

[3] Weifang Med Univ, Affiliated Hosp, Weifang 261031, Shandong, Peoples R China

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2013年 / 69卷

关键词：

AKT; ABL; Protein kinase; HUVECs; Rat thoracic aorta rings; TUMOR-GROWTH; IN-VITRO; SULFONAMIDE; ANALOGS; DESIGN; AGENTS;

D O I：

10.1016/j.ejmech.2013.07.056

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of 4-amino-2-(thio)phenol derivatives were well synthesized. The preliminary biological test revealed that several compounds displayed high specific protein kinase and angiogenesis inhibitory activities compared with previous work mainly because of the substitution of sulfonamide structure for amide fragment. Among which, compound 5i was identified to inhibit protein kinase B/AKT (IC50 = 1.26 mu M) and ABL tyrosine kinase (IC50 = 1.50 mu M) effectively. Meanwhile, compound 5i demonstrated competitive in vitro antiangiogenic activities to Pazopanib in both human umbilical vein endothelial cell (HUVEC) tube formation assay and the rat thoracic aorta rings test. (C) 2013 Elsevier Masson SAS. All rights reserved.

引用

页码：191 / 200

页数：10

共 50 条

[21] Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer
Fang, Bo
Lai, Yinshuang
Yan, Hao
Ma, Yue
Ni, Zefeng
Zhu, Qianqian
Zhang, Jianxia
Ye, Yanfei
Wang, Mengying
Wang, Peipei
Wang, Yan
Zhang, Shuyuan
Hui, Min
Wang, Dalong
Zhao, Yunjie
Li, Xiaokun
Wang, Kun
Liu, Zhiguo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
[22] Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2
Guillon, Jean
Le Borgne, Marc
Rimbault, Charlotte
Moreau, Stephane
Savrimoutou, Solene
Pinaud, Noel
Baratin, Sophie
Marchivie, Mathieu
Roche, Severine
Bollacke, Andre
Pecci, Adali
Alvarez, Lautaro
Desplat, Vanessa
Jose, Joachim
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 65 : 205 - 222
[23] Design, synthesis and biological evaluation of bisnoralcohol derivatives as novel IRF4 inhibitors for the treatment of multiple myeloma
Zhang, Jing-Zan
Zhang, Lin
Ding, Xin
Wu, Min
Zhang, De-Jie
Wu, Yujie
Liu, Mingyao
Li, Chen-Chen
Yi, Zhengfang
Qiu, Wen-Wei
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 285
[24] Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
Zhang, Rui
Li, Heng
Zhang, Xianglei
Li, Jian
Su, Haixia
Lu, Qiukai
Dong, Guangyu
Dou, Huixia
Fan, Chen
Gu, Zhanni
Mu, Qianwen
Tang, Wei
Xu, Yechun
Liu, Hong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 211
[25] Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)
Lin, Songnian
Malkani, Sunita
Lombardo, Matthew
Yang, Lihu
Mills, Sander G.
Chapman, Kevin
Thompson, James E.
Zhang, Wen Xiao
Wang, Ruixiu
Cubbon, Rose M.
O'Neill, Edward A.
Hale, Jeffrey J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (22) : 5402 - 5408
[26] Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors
Arcari, Joel T.
Beebe, Jean S.
Berliner, Martin A.
Bernardo, Vincent
Boehm, Merin
Borzillo, Gary V.
Clark, Tracey
Cohen, Bruce D.
Connell, Richard D.
Frost, Heather N.
Gordon, Deborah A.
Hungerford, William M.
Kakar, Shefali M.
Kanter, Aaron
Keene, Nandell F.
Knauth, Elizabeth A.
LaGreca, Susan D.
Lu, Yong
Martinez-Alsina, Louis
Marx, Matthew A.
Morris, Joel
Patel, Nandini C.
Savage, Doug
Soderstrom, Cathy I.
Thompson, Carl
Tkalcevic, George
Tom, Norma J.
Vajdos, Felix F.
Valentine, James J.
Vincent, Patrick W.
Wessel, Matthew D.
Chen, Jinshan M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (10) : 3059 - 3063
[27] Synthesis and Biological Evaluation of 2,4,6-Trihydroxychalcone Derivatives as Novel Protein Tyrosine Phosphatase 1B Inhibitors
Sun, Liang-Peng
Gao, Li-Xin
Ma, Wei-Ping
Nan, Fa-Jun
Li, Jia
Piao, Hu-Ri
CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (04) : 584 - 590
[28] Synthesis and Anticancer Evaluation of Novel Derivatives of Isoxazolo[4,5-e][1,2,4]triazepine Derivatives and Potential Inhibitors of Protein Kinase C
Wagner, Edwin
Wietrzyk, Joanna
Psurski, Mateusz
Becan, Lilianna
Turlej, Eliza
ACS OMEGA, 2021, 6 (01): : 119 - 134
[29] Synthesis and biological evaluation of 2,4-diaminoquinazoline derivatives as novel heat shock protein 90 inhibitors
Thorat, Dhanaji Achyutrao
Doddareddy, Munikumar Reddy
Seo, Seon Hee
Hong, Tae-Joon
Cho, Yong Seo
Hahn, Ji-Sook
Pae, Ae Nim
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1593 - 1597
[30] Discovery of novel dihydroimidazothiazole derivatives as p53-MDM2 protein-protein interaction inhibitors: Synthesis, biological evaluation and structure-activity relationships
Miyazaki, Masaki
Kawato, Haruko
Naito, Hiroyuki
Ikeda, Masahiro
Miyazaki, Masaya
Kitagawa, Mayumi
Seki, Takahiko
Fukutake, Setsuko
Aonuma, Masashi
Soga, Tsunehiko
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (20) : 6338 - 6342

← 1 2 3 4 5 →